WO2000035418A3 - Chewable drug delivery system - Google Patents
Chewable drug delivery system Download PDFInfo
- Publication number
- WO2000035418A3 WO2000035418A3 PCT/US1999/030119 US9930119W WO0035418A3 WO 2000035418 A3 WO2000035418 A3 WO 2000035418A3 US 9930119 W US9930119 W US 9930119W WO 0035418 A3 WO0035418 A3 WO 0035418A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- delivery system
- drug delivery
- oral cavity
- chewable
- chewable drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU23679/00A AU2367900A (en) | 1998-12-18 | 1999-12-16 | Chewable drug delivery system |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21570798A | 1998-12-18 | 1998-12-18 | |
US09/215,707 | 1998-12-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000035418A2 WO2000035418A2 (en) | 2000-06-22 |
WO2000035418A3 true WO2000035418A3 (en) | 2000-12-21 |
Family
ID=22804049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/030119 WO2000035418A2 (en) | 1998-12-18 | 1999-12-16 | Chewable drug delivery system |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2367900A (en) |
WO (1) | WO2000035418A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6200604B1 (en) * | 1998-03-27 | 2001-03-13 | Cima Labs Inc. | Sublingual buccal effervescent |
US6974590B2 (en) | 1998-03-27 | 2005-12-13 | Cima Labs Inc. | Sublingual buccal effervescent |
US6350470B1 (en) | 1998-04-29 | 2002-02-26 | Cima Labs Inc. | Effervescent drug delivery system for oral administration |
US20020119192A1 (en) * | 2000-09-22 | 2002-08-29 | Vishwanathan Narayanan Badri | Controlled release formulations for oral administration |
DE10107659B4 (en) * | 2001-02-19 | 2008-03-13 | Lts Lohmann Therapie-Systeme Ag | Mucoadhesive disintegratable drug preparation for drug administration in veterinary and human medicine |
US20030068356A1 (en) * | 2001-07-10 | 2003-04-10 | Pather S. Indiran | Sequential drug delivery systems |
US20030124196A1 (en) | 2001-08-22 | 2003-07-03 | Susan Weinbach | Pulsatile release compositions and methods for enhanced intestinal drug absorption |
WO2006044595A2 (en) * | 2004-10-13 | 2006-04-27 | Cadbury Adams Usa Llc | Effervescent pressed gum tablet compositions |
WO2009125432A2 (en) * | 2008-04-11 | 2009-10-15 | Lupin Limited | Gas empowered expandable drug delivery systems |
RU2493829C2 (en) * | 2008-08-22 | 2013-09-27 | РЕКИТТ БЕНКАЙЗЕР ХЕЛТКЭА (Ю Кей) ЛИМИТЕД | Improvement of compositions or whatever is relevant to compositions |
JP6526956B2 (en) * | 2013-12-19 | 2019-06-05 | 花王株式会社 | Solid composition |
EP4208155A1 (en) * | 2020-09-03 | 2023-07-12 | Elanco Tiergesundheit AG | Chewable formulations |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0424706A1 (en) * | 1989-10-25 | 1991-05-02 | Pharmatrans Sanaq Ag | Chewable or suckable pharmaceutical form, process for its preparation and its use |
DE19802700A1 (en) * | 1998-01-24 | 1999-07-29 | Bayer Ag | Preparation of fast-dissolving tablets for controlling blood sugar levels |
-
1999
- 1999-12-16 WO PCT/US1999/030119 patent/WO2000035418A2/en active Application Filing
- 1999-12-16 AU AU23679/00A patent/AU2367900A/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0424706A1 (en) * | 1989-10-25 | 1991-05-02 | Pharmatrans Sanaq Ag | Chewable or suckable pharmaceutical form, process for its preparation and its use |
DE19802700A1 (en) * | 1998-01-24 | 1999-07-29 | Bayer Ag | Preparation of fast-dissolving tablets for controlling blood sugar levels |
Also Published As
Publication number | Publication date |
---|---|
AU2367900A (en) | 2000-07-03 |
WO2000035418A2 (en) | 2000-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2388610A1 (en) | Oral transmucosal drug dosage using solid solution | |
CA2365826A1 (en) | Over-coated chewing gum formulations | |
CA2426349A1 (en) | Over-coated chewing gum formulations including tableted center | |
CA2258095A1 (en) | Tetrahydrolipstatin containing compositions | |
WO2000019985A3 (en) | New sustained release oral formulations | |
AU1227899A (en) | Osmotic medicament releasing system | |
AU3853895A (en) | Pharmaceutical composition comprising non-steroidal anti-inflammatory drugs | |
IL150127A0 (en) | Flat medicinal preparation for transmucosal administration of oxycodon or a comparable active ingredient in the oral cavity, for use in pain therapy and in addiction therapy | |
CA2337046A1 (en) | Sustained release pharmaceutical preparation | |
HUP0101246A3 (en) | Novel galenic formulations of meloxicam for oral administration and process for their preparation | |
ZA964735B (en) | Compositions and methods for topical administration of pharmaceutically active agents | |
HUP0004383A2 (en) | Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient | |
WO2003047519A3 (en) | 'compressed annular tablet with molded triturate tablet for oral and intraoral' | |
AU2513900A (en) | Drug dosage unit for buccal administration of steroidal active agents | |
WO2002017918A3 (en) | Sustained release formulations for growth hormone secretagogues | |
WO2000035418A3 (en) | Chewable drug delivery system | |
AU2001263228A1 (en) | Rapidly disintegrating solid oral dosage form | |
WO2000041681A3 (en) | MEDICINAL FORMULATIONS CONTAINING AN OPIOID AND AN α-ANTAGONIST | |
AU2223095A (en) | Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules | |
WO1999007401A3 (en) | The use of erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases | |
AU6755700A (en) | Frozen product and method of oral delivery of active ingredients | |
WO2000013662A3 (en) | Medicated chewing gum delivery system for nicotine | |
HK1040920A1 (en) | Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent. | |
WO2002011694A3 (en) | Compositions and dosage forms for application in the oral cavity in the treatment of mykoses | |
PL348202A1 (en) | Pharmaceutically active composition and dispensing device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |